4D Molecular Therapeutics, Inc.FDMTNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank88
3Y CAGR+97.1%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+97.1%/yr
vs +31.5%/yr prior
Acceleration
+65.6pp
Accelerating
Percentile
P88
Within normal range
vs 3Y Ago
7.7x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $19.44M | -27.9% |
| 2024 | $26.97M | +124.2% |
| 2023 | $12.03M | +374.0% |
| 2022 | $2.54M | +15762.5% |
| 2021 | $16000.00 | +155.2% |
| 2020 | $-29000.00 | -102.0% |
| 2019 | $1.46M | +71.9% |
| 2018 | $848000.00 | +1630.6% |
| 2017 | $49000.00 | - |